These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 8406050)

  • 41. CHD and diabetes--target dyslipidaemia, reduce the risk.
    Betteridge DJ; Tuomilehto J
    Diabetes Res Clin Pract; 2003 Jul; 61 Suppl 1():S1-2. PubMed ID: 12880688
    [No Abstract]   [Full Text] [Related]  

  • 42. "Interventional lipidology": tomographic plaque imaging and aggressive treatment of metabolic disorders.
    Hecht HS
    Am J Cardiol; 2002 Aug; 90(3):268-70. PubMed ID: 12127614
    [No Abstract]   [Full Text] [Related]  

  • 43. [Progress in the treatment of hyperlipidemia. Diet and exercise therapies].
    Sasaki J
    Nihon Naika Gakkai Zasshi; 2001 Oct; 90(10):1990-5. PubMed ID: 11769489
    [No Abstract]   [Full Text] [Related]  

  • 44. Connections between obesity and dyslipidaemia.
    Denke MA
    Curr Opin Lipidol; 2001 Dec; 12(6):625-8. PubMed ID: 11801862
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prevention of cardiovascular atherosclerotic disease in dyslipidemic children.
    Pongiglione R; Rondinone R
    Beitr Infusionsther; 1989; 22():60-1. PubMed ID: 2468387
    [No Abstract]   [Full Text] [Related]  

  • 46. [Problem-oriented laboratory findings of lipid parameters].
    Blazej V; Dusková S; Hudcová M
    Cas Lek Cesk; 1982 Oct; 121(41):1266-9. PubMed ID: 6897373
    [No Abstract]   [Full Text] [Related]  

  • 47. Question: In men with risk factors for coronary artery disease, does initiating lipid screening earlier than 35 years of age reduce cardiovascular events?
    Smith J; McGhee P; Nguyen N; Palmer P
    J Okla State Med Assoc; 2018 Mar; 111(3):560-561. PubMed ID: 30568317
    [No Abstract]   [Full Text] [Related]  

  • 48. New intriguing subsets of pediatric hyperlipidemia patients.
    Congenit Heart Dis; 2018 Nov; 13(6):883. PubMed ID: 30570228
    [No Abstract]   [Full Text] [Related]  

  • 49. Drug treatment of lipid disorders.
    Dorn J; Naughton J; Galletti C
    N Engl J Med; 1999 Dec; 341(26):2020; author reply 2021. PubMed ID: 10617401
    [No Abstract]   [Full Text] [Related]  

  • 50. Lipid-lowering effect of simvastatin in patients of type 2 diabetes mellitus.
    Udawat H; Goyal RK
    Indian Heart J; 2001; 53(2):172-6. PubMed ID: 11428472
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Management of hypercholesterolaemia in the patient with diabetes.
    Packard C; Olsson AG
    Int J Clin Pract Suppl; 2002 Jul; (130):27-32. PubMed ID: 12296606
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmacologic treatment of type 2 diabetic dyslipidemia.
    Moon YS; Kashyap ML
    Pharmacotherapy; 2004 Dec; 24(12):1692-713. PubMed ID: 15585439
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hyperlipidemia in children with type 2 diabetes mellitus.
    Taha D
    J Pediatr Endocrinol Metab; 2002 Apr; 15 Suppl 1():505-7. PubMed ID: 12017224
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Diabetes and heart disease: a new strategy for managing lipid disorders.
    Garber AJ
    Geriatrics; 1993 Oct; 48(10):34-6, 39-41. PubMed ID: 8406050
    [TBL] [Abstract][Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.